Search Results 1801-1810 of 39013 for Two-phase

  1. A Study of Pembrolizumab Alone as Therapy for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  3. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  4. Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Bicuspid aortic valve - Overview - Mayo Clinic

    A bicuspid valve has only two cusps. Rarely, some people are born with an aortic valve that has one cusp or four cusps. A valve with one cusp is called ...

  6. 2-D Speckle Tracking in Diagnosis and Prognosis of Acute Myocarditis - Mayo Clinic

    In this study, we attempt to evaluate the LV and RV myocardial mechanical properties in patients with myocarditis during the acute and convalescent phases.

  7. A Study Of IBI363 In Subjects With Advanced Solid Malignancies - Mayo Clinic

    About this study. This is a Phase 2, open-label, multicenter study designed to evaluate the efficacy, safety and tolerability of IBI363 (study drug) in ...

  8. Folliculitis - Symptoms & causes - Mayo Clinic

    This type is a rash of round, itchy bumps that can show up 1 to 2 days after exposure to the bacteria that causes it. Hot tub folliculitis is caused by ...

  9. Nonalcoholic fatty liver disease - Survival rates - Mayo Clinic

    On average, people with MASH move to the next stage of fibrosis approximately every seven years, compared with every 14 years in those with MASLD. People who ...

  10. Efficacy And Safety Of Nintedanib In Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... stage of disease, and previous treatments or health concerns. ... 2, rituximab ...